Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Daily Top 10 COVID-19 publications

Deutsch | English | Español | Français | Italiano | Português; | Tiếng Việt | Türkçe

  Obstructive Lung Diseases

  Free Subscription


3 Allergy
3 Am J Respir Crit Care Med
3 Arch Bronconeumol
1 Arch Dis Child
2 Chest
2 Eur Respir J
1 J Allergy Clin Immunol
3 J Asthma
1 Lancet
5 N Engl J Med
2 Pediatr Pulmonol
2 Pediatrics
1 PLoS One
4 Respir Med
1 Rev Mal Respir
1 Thorax

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles


  1. SOKOLOWSKA M, Rovati GE, Diamant Z, Untersmayr E, et al
    Current perspective on eicosanoids in asthma and allergic diseases - EAACI Task Force consensus report, part I.
    Allergy. 2020 Apr 12. doi: 10.1111/all.14295.
    PubMed         Abstract available

  2. LEMONNIER N, Melen E, Jiang Y, Joly S, et al
    A novel whole blood gene expression signature for asthma, dermatitis and rhinitis multimorbidity in children and adolescents.
    Allergy. 2020 Apr 11. doi: 10.1111/all.14314.
    PubMed         Abstract available

  3. SCHULER CF 4TH, Malinczak CA, Best SKK, Morris SB, et al
    Inhibition of uric acid or IL-1beta ameliorates respiratory syncytial virus immunopathology and development of asthma.
    Allergy. 2020 Apr 10. doi: 10.1111/all.14310.
    PubMed         Abstract available

    Am J Respir Crit Care Med

  4. LI J, Panganiban R, Kho AT, McGeachie MJ, et al
    Circulating MicroRNAs and Treatment Response in Childhood Asthma.
    Am J Respir Crit Care Med. 2020 Apr 9. doi: 10.1164/rccm.201907-1454.
    PubMed         Abstract available

  5. RASTOGI D, Johnston AD, Nico J, Loh LN, et al
    Functional Genomics of the Pediatric Obese Asthma Phenotype Reveal Enrichment of Rho-GTPase Pathways.
    Am J Respir Crit Care Med. 2020 Apr 7. doi: 10.1164/rccm.201906-1199.
    PubMed         Abstract available

  6. GOMEZ JL, Chen A, Diaz MP, Zirn N, et al
    A Network of Sputum MicroRNAs is Associated with Neutrophilic Airway Inflammation in Asthma.
    Am J Respir Crit Care Med. 2020 Apr 7. doi: 10.1164/rccm.201912-2360.
    PubMed         Abstract available

    Arch Bronconeumol

  7. MARTINEZ-GARCIA MA, Maiz L, Olveira C, Giron RM, et al
    Erratum to Spanish Guidelines on the Evaluation and Diagnosis of Bronchiectasis in Adults [Arch Bronconeumol. 2018;54(2):79-87].
    Arch Bronconeumol. 2020;56:265.

  8. GARRIDO OCANA AI, Gonzalez Fernandez-Palacios M, Matute de Cardenas JA, Rosso Gonzalez ML, et al
    Successful Lobectomy in Preterm With Diffuse Persistent Interstitial Pulmonary Emphysema.
    Arch Bronconeumol. 2020 Apr 2. pii: S0300-2896(19)30590.

  9. CHEN CL, Huang Y, Yuan JJ, Li HM, et al
    The Roles of Bacteria and Viruses in Bronchiectasis Exacerbation: A Prospective Study.
    Arch Bronconeumol. 2020 Apr 7. pii: S0300-2896(19)30616.
    PubMed         Abstract available

    Arch Dis Child

  10. SINHA I, Quint J, Roberts M
    Improving outcomes for children with asthma: role of national audit.
    Arch Dis Child. 2020 Apr 7. pii: archdischild-2019-318576.


  11. KAVANAGH JE, d'Ancona G, Elstad M, Green L, et al
    Real-World Effectiveness and the Characteristics of a 'Super-Responder' to Mepolizumab in Severe Eosinophilic Asthma.
    Chest. 2020 Apr 7. pii: S0012-3692(20)30574-2. doi: 10.1016/j.chest.2020.
    PubMed         Abstract available

  12. MCSHANE PJ, Aksamit TR
    Repurposing the COPD Assessment Test: Another Step Forward for Bronchiectasis.
    Chest. 2020;157:749-750.

    Eur Respir J

  13. NEALE J, Orme MW, Majd S, Chantrell S, et al
    A comparison of daily physical activity profiles between adults with severe asthma and healthy controls.
    Eur Respir J. 2020 Apr 7. pii: 13993003.02219-2019.

  14. CRICHTON ML, Lonergan M, Barker AF, Sibila O, et al
    Inhaled Aztreonam improves symptoms of cough and sputum production in patients with bronchiectasis: a post-hoc analysis of the AIR-BX studies.
    Eur Respir J. 2020 Apr 7. pii: 13993003.00608-2020.
    PubMed         Abstract available

    J Allergy Clin Immunol

  15. BOGDANOV V, Herzog M, Kazopoulos T, Grafmans D, et al
    J Allergy Clin Immunol. 2020 Apr 4. pii: S0091-6749(20)30413.

    J Asthma

  16. PADE KH, Thompson LR, Ravandi B, Chang TP, et al
    Parental Perception of a Picture-Based Chronic Asthma Care Management Tool in an Urban Pediatric Emergency Department.
    J Asthma. 2020 Apr 5:1-16. doi: 10.1080/02770903.2020.1753210.
    PubMed         Abstract available

  17. WIDHIANINGSIH D, Koontongkaew S
    Enhancement of cariogenic virulence properties of dental plaque in asthmatics.
    J Asthma. 2020 Apr 6:1-10. doi: 10.1080/02770903.2020.1753211.

  18. MARQUES MELLO L, Viana KP, Moraes Dos Santos F, Saturnino LTM, et al
    Severe asthma and eligibility for biologics in a Brazilian cohort.
    J Asthma. 2020 Apr 9:1-9. doi: 10.1080/02770903.2020.1748049.
    PubMed         Abstract available


  19. HINKAMP CA, Keshvani N
    Emphasising classification in emphysematous pyelonephritis.
    Lancet. 2020;395:1145.

    N Engl J Med

  20. REESE Z, Ganatra RB
    Metoprolol for the Prevention of Exacerbations of COPD.
    N Engl J Med. 2020;382:1374.

  21. DOUMAS M, Imprialos KP, Stavropoulos K
    Metoprolol for the Prevention of Exacerbations of COPD.
    N Engl J Med. 2020;382:1374-1375.

    Metoprolol for the Prevention of Exacerbations of COPD.
    N Engl J Med. 2020;382:1375.

  23. DRANSFIELD MT, Helgeson ES, Connett JE
    Metoprolol for the Prevention of Exacerbations of COPD. Reply.
    N Engl J Med. 2020;382:1375-1376.

  24. GODSON C
    Balancing the Effect of Leukotrienes in Asthma.
    N Engl J Med. 2020;382:1472-1475.

    Pediatr Pulmonol

  25. MOLINA AL, Molina Y, Walley SC, Wu CL, et al
    Residential instability, neighborhood deprivation, and pediatric asthma outcomes.
    Pediatr Pulmonol. 2020 Apr 10. doi: 10.1002/ppul.24771.
    PubMed         Abstract available

  26. HARVEY SM, Murphy VE, Gibson PG, Collison A, et al
    Maternal asthma, breastfeeding, and respiratory outcomes in the first year of life.
    Pediatr Pulmonol. 2020 Apr 6. doi: 10.1002/ppul.24756.
    PubMed         Abstract available


  27. DUNN M, Muthu N, Burlingame CC, Gahman AM, et al
    Reducing Albuterol Use in Children With Bronchiolitis.
    Pediatrics. 2020;145.
    PubMed         Abstract available

  28. WOLFE I, Satherley RM, Scotney E, Newham J, et al
    Integrated Care Models and Child Health: A Meta-analysis.
    Pediatrics. 2020;145.
    PubMed         Abstract available

    PLoS One

  29. BERASTEGUI C, Gomez-Olles S, Mendoza-Valderrey A, Pereira-Veiga T, et al
    Use of serum KL-6 level for detecting patients with restrictive allograft syndrome after lung transplantation.
    PLoS One. 2020;15:e0226488.
    PubMed         Abstract available

    Respir Med

  30. CANONICA GW, Malvezzi L, Blasi F, Paggiaro P, et al
    Chronic rhinosinusitis with nasal polyps impact in severe asthma patients: Evidences from the Severe Asthma Network Italy (SANI) registry.
    Respir Med. 2020;166:105947.
    PubMed         Abstract available

  31. VETRANO DL, Zucchelli A, Bianchini E, Marconi E, et al
    Patterns of oral corticosteroids use in primary care patients with severe asthma.
    Respir Med. 2020;166:105946.
    PubMed         Abstract available

  32. IMAM JS, Duarte AG
    Non-CF bronchiectasis: Orphan disease no longer.
    Respir Med. 2020;166:105940.
    PubMed         Abstract available

  33. LAVORINI F, Bianco A, Blasi F, Braido F, et al
    What drives inhaler prescription for asthma patients? Results from a real-life retrospective analysis.
    Respir Med. 2020;166:105937.
    PubMed         Abstract available

    Rev Mal Respir

  34. COETMEUR D, Parrat E, Nocent-Ejnaini C, Mangiapan G, et al
    [Physical activity in severe asthma: Results of the FASE-CPHG Study].
    Rev Mal Respir. 2020 Apr 7. pii: S0761-8425(20)30029.
    PubMed         Abstract available


  35. Correction: Antimicrobial peptides, disease severity and exacerbations in bronchiectasis.
    Thorax. 2020 Apr 9. pii: thoraxjnl-2018-212895.

Thank you for your interest in scientific medicine.

AMEDEO Obstructive Lung Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.